Estados financieros detallados de Aldeyra The (ALDX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.37, ALDX presenta beneficios negativos (P/E no significativo) y un ROE del -53.14%. La capitalización bursátil es de $83M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | $37849 | $71003 | $96305 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$35792 | -$37849 | -$71003 | -$96305 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $13.2M | $16.3M | $29.8M | $44.4M | $24.7M | $44.9M | $47.3M | $29.5M | $48.2M | $25.7M |
| Generales y Administrativos | $5.5M | $6.2M | $9.9M | $12.2M | $10.0M | $11.3M | $15.4M | $13.3M | $11.9M | $9.6M |
| Gastos Operativos | $18.7M | $22.5M | $39.7M | $56.5M | $34.7M | $56.2M | $62.7M | $42.8M | $60.1M | $35.3M |
| Beneficio Operativo | -$18.7M | -$22.5M | -$39.7M | -$63.1M | -$36.4M | -$56.2M | -$62.7M | -$42.8M | -$60.1M | -$35.3M |
| EBITDA | -$18.6M | -$22.2M | -$38.7M | -$61.4M | -$34.3M | -$55.8M | -$60.1M | -$35.2M | -$53.7M | -$31.7M |
| Gastos por Intereses | $105509 | $113454 | $146792 | $603846 | $1.9M | $1.7M | $1.7M | $2.1M | $1.9M | $1.9M |
| Beneficio Antes de Impuestos | -$18.7M | -$22.3M | -$38.9M | -$62.1M | -$38.0M | -$57.8M | -$62.0M | -$37.5M | -$55.9M | -$33.8M |
| Impuestos | $66245 | $223403 | 0 | -$1.3M | -$479265 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$18.7M | -$22.3M | -$38.9M | -$60.8M | -$37.6M | -$57.8M | -$62.0M | -$37.5M | -$55.9M | -$33.8M |
| BPA | $-1.65 | $-1.40 | $-1.79 | $-2.24 | $-1.11 | $-1.07 | $-1.06 | $-0.64 | $-0.94 | $-0.56 |
| BPA Diluido | $-1.65 | $-1.40 | $-1.79 | $-2.24 | $-1.11 | $-1.07 | $-1.06 | $-0.64 | $-0.94 | $-0.56 |
| Acciones en Circulación (Diluidas) | $11.4M | $15.9M | $21.7M | $27.1M | $34.0M | $54.0M | $58.4M | $58.9M | $59.5M | $60.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$66599 | 0 |
| Beneficio Operativo | -$8.0M | -$6.7M | -$3.5M | -$5.9M |
| EBITDA | -$7.1M | -$5.9M | -$2.9M | -$5.4M |
| Beneficio Neto | -$7.7M | -$6.5M | -$3.5M | -$5.5M |
| BPA | $-0.13 | $-0.11 | $-0.06 | $-0.09 |
| BPA Diluido | $-0.13 | $-0.11 | $-0.06 | $-0.09 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $12.0M | $20.0M | $47.4M | $44.4M | $77.9M | $229.8M | $144.4M | $142.8M | $54.5M | $70.0M |
| Inversiones a Corto | $12.9M | $22.9M | $46.2M | $28.9M | 0 | 0 | $29.9M | 0 | $46.6M | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | $28770 | $3.2M | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.1M | $44.0M | $94.8M | $75.2M | $83.1M | $232.8M | $181.0M | $147.8M | $104.1M | $71.8M |
| Inmovilizado Material | $56352 | $43262 | $235225 | $349456 | $293235 | $384350 | $268544 | $516578 | $266955 | $275861 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25.2M | $44.2M | $95.1M | $75.5M | $83.4M | $233.1M | $181.3M | $148.3M | $104.6M | $72.1M |
| Cuentas por Pagar | $275441 | $1.0M | $3.1M | $808302 | $381638 | $1.0M | $133625 | $1.3M | $180453 | $158461 |
| Deuda a Corto | $77546 | $116319 | 0 | 0 | $3.7M | 0 | $911763 | $15.1M | $31372 | $15.2M |
| Pasivos Corrientes | $2.3M | $3.4M | $8.5M | $12.9M | $12.4M | $11.8M | $15.4M | $22.3M | $18.6M | $27.8M |
| Deuda a Largo | $1.2M | $1.2M | 0 | $14.5M | $11.4M | $15.5M | $14.9M | 0 | $15.0M | 0 |
| Pasivos Totales | $3.5M | $4.6M | $8.5M | $27.4M | $23.8M | $27.4M | $30.3M | $28.5M | $33.6M | $27.8M |
| Reservas | -$77.3M | -$99.6M | -$138.5M | -$199.4M | -$236.9M | -$294.7M | -$356.7M | -$394.3M | -$450.1M | -$484.0M |
| Patrimonio Neto | $21.6M | $39.6M | $86.6M | $48.1M | $59.5M | $205.7M | $151.0M | $119.8M | $71.0M | $44.3M |
| Deuda Total | $1.3M | $1.3M | 0 | $14.8M | $15.3M | $15.9M | $16.1M | $15.7M | $15.3M | $15.5M |
| Deuda Neta | -$23.6M | -$41.6M | -$93.6M | -$58.6M | -$62.5M | -$213.9M | -$158.2M | -$127.2M | -$85.8M | -$54.5M |
| Capital Circulante | $22.8M | $40.6M | $86.3M | $62.3M | $70.6M | $221.0M | $165.7M | $125.6M | $85.5M | $44.0M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $59.3M | $70.0M | $65.0M | $45.1M |
| Activos Totales | $77.8M | $72.1M | $66.5M | $47.5M |
| Pasivos Totales | $28.6M | $27.8M | $24.3M | $9.7M |
| Patrimonio Neto | $49.2M | $44.3M | $42.2M | $37.9M |
| Deuda Total | $15.5M | $15.5M | $15.5M | $143447 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$18.7M | -$22.3M | -$38.9M | -$60.8M | -$37.6M | -$57.8M | -$62.0M | -$37.5M | -$55.9M | -$33.8M |
| Amortizaciones | $35792 | $37849 | $71003 | $96305 | $56221 | $264180 | $258707 | $262780 | $249623 | $251993 |
| Compensación en Acciones | $2.8M | $2.7M | $4.1M | $8.1M | $7.1M | $7.1M | $8.3M | $5.8M | $8.0M | $6.1M |
| Cambio en Capital Circulante | $462973 | $215451 | $5.0M | $2.7M | -$8.8M | $7.4M | -$3.4M | $861180 | $5.9M | -$5.2M |
| Flujo de Caja Operativo | -$15.1M | -$19.2M | -$29.9M | -$45.0M | -$37.5M | -$42.6M | -$56.6M | -$30.3M | -$43.2M | -$33.3M |
| Inversiones (CapEx) | -$11810 | -$24759 | -$262966 | -$9529 | 0 | -$7806 | -$16317 | 0 | 0 | 0 |
| Adquisiciones | $11810 | $24.76B | $262.97B | $609464 | 0 | 0 | $16317 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$15.2M | -$19.2M | -$30.1M | -$45.0M | -$37.5M | -$42.6M | -$56.7M | -$30.3M | -$43.2M | -$33.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$7.0M | -$5.3M | -$5.1M | -$4.6M |
| Inversiones (CapEx) | 0 | 0 | 0 | -$23098 |
| Flujo de Caja Libre | -$7.0M | -$5.3M | -$5.1M | -$4.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.6M | $1.1M | -$987554 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -19.5% | -74.1% | -56.4% | +38.3% | -53.8% | -7.4% | +39.5% | -48.8% | +39.4% |
| Crecimiento BPA (anual) | | +15.2% | -27.9% | -25.1% | +50.4% | +3.6% | +0.9% | +39.6% | -46.9% | +40.4% |
| Cambio en Acciones (anual) | | +40.3% | +36.2% | +25.0% | +25.3% | +59.1% | +8.1% | +0.9% | +0.9% | +1.0% |
| Crecimiento FCF (anual) | | -27.0% | -56.5% | -49.4% | +16.7% | -13.5% | -33.1% | +46.5% | -42.5% | +22.8% |
| Tasa Impositiva Efectiva | -0.4% | -1.0% | -0.0% | 2.1% | 1.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-1.34 | $-1.21 | $-1.39 | $-1.66 | $-1.10 | $-0.79 | $-0.97 | $-0.51 | $-0.73 | $-0.56 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $11.4M | $15.9M | $21.7M | $27.1M | $34.0M | $54.0M | $58.4M | $58.9M | $59.5M | $60.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -53.14% |
| Rentabilidad sobre capital invertido | -63.28% |
| Rentabilidad sobre activos | -48.49% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 4.91 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.57 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -3.24 | -4.86 | -4.64 | -2.59 | -6.18 | -3.74 | -6.57 | -5.48 | -5.31 | -9.25 |
| P/VC | 2.81 | 2.73 | 2.08 | 3.28 | 3.92 | 1.05 | 2.69 | 1.73 | 4.18 | 7.03 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |